3-Pyridinylboronic acid → HCID 57595853, compound
Reaction equation
C[O:2][C:3]([C:5]1[S:9][C:8]([N:10]2[C:14]3[CH:15]=[C:16]([O:21][CH3:22])[C:17]([O:19][CH3:20])=[CH:18][C:13]=3[N:12]=[CH:11]2)=[N:7][C:6]=1Br)=[O:4].[N:24]1[CH:29]=[CH:28][CH:27]=[C:26](B(O)O)[CH:25]=1>>[CH3:20][O:19][C:17]1[C:16]([O:21][CH3:22])=[CH:15][C:14]2[N:10]([C:8]3[S:9][C:5]([C:3]([OH:2])=[O:4])=[C:6]([C:26]4[CH:25]=[N:24][CH:29]=[CH:28][CH:27]=4)[N:7]=3)[CH:11]=[N:12][C:13]=2[CH:18]=1Participants
3
Procedure
In a similar manner as described for Example 26, 4-bromo-2-(5,6-dimethoxy-benzoimidazol-1-yl)-thiazole-5-carboxylic acid methyl ester (40 mg, 0.1 mmol) and pyridine-3-boronic acid (18.4 mg, 0.15 mmol) gave 2-(5,6-Dimethoxy-benzoimidazol-1-yl)-4-pyridin-3-yl-thiazole-5-carboxylic acid (2.6 mg, 7%) as a white solid. 1H NMR (400 MHz, DMSO-d6) δ ppm 13.68 (br.s., 1 H); 9.07 (d, 1H); 8.85 (s, 1 H); 8.66 (dd, 1 H); 8.31 (dt, 1 H); 7.81 (s, 1 H); 7.55 (ddd, 1 H); 7.40 (s, 1 H); 3.86 (s, 3 H); 3.85 (s, 3 H). MS m/z 383 (M+1).
Sources & evidence
- ORD record
- ord-9bbef3dc2cee4b7ea9e5066d534c6f9a
- Source dataset
- uspto-grants-2009_03
- Patent number
- US07504513B2
Reaction notes
Loading…